Fresenius Kabi Recalls Morphine Sulfate Injection Due to Labeling Error
Fresenius Kabi is recalling one lot of Morphine Sulfate Injection due to a labeling mix-up that could lead to medication errors.
Asset / Drug
Drug and asset intelligence for Fresenius with 4 indexed intelligence signals across regulatory, clinical, competitive, and market developments.
No catalysts indexed for this entity yet.
No catalysts indexed for this entity yet.
No related entities indexed yet.
Newsletter
Concise strategic intelligence on regulatory, clinical, competitive, and market developments — free to subscribe.
No paywall. No spam. Unsubscribe anytime.